2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
131
Brain Neoplasms
128
Prostatic Neoplasms
108
Neoplasm Metastasis
88
Lung Neoplasms
73
Carcinoma, Hepatocellular
71
Pancreatic Neoplasms
69
Breast Neoplasms
49
Melanoma
44
Carcinoma, Renal Cell
36
Neoplasms
34
Colorectal Neoplasms
26
Squamous Cell Carcinoma of Head and Neck
25
Glioblastoma
24
Liver Neoplasms
20
Head and Neck Neoplasms
17
Small Cell Lung Carcinoma
15
Sarcoma
13
Kidney Neoplasms
13
Glioma
12
Urinary Bladder Neoplasms
10
Recurrence
9
Gliosarcoma
8
Ovarian Neoplasms
7
Central Nervous System Neoplasms
7
Adenocarcinoma of Lung
7
Adenocarcinoma
7
Radiation Injuries
6
Prostate Cancer Metastatic
6
Neuroma, Acoustic
6
Interventions
Cyclophosphamide
23
blinatumomab
18
Cytarabine
16
fludarabine
13
Azacitidine
12
venetoclax
10
fludarabine phosphate
10
Rituximab
8
Blood Specimen Collection
8
Methotrexate
7
Lenalidomide
7
Dexamethasone
7
Daunorubicin
7
Mercaptopurine
6
Vincristine
5
daratumumab
4
Whole-Body Irradiation
4
Melphalan
4
Idarubicin
4
Etoposide
4
Drug Therapy
4
Busulfan
4
pembrolizumab
3
obinutuzumab
3
Radiotherapy
3
Neoadjuvant Therapy
3
Maintenance
3
Liquid Biopsy
3
Immunotherapy, Adoptive
3
Imatinib Mesylate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Radiosurgery
×
Clear all
NCT04944173
2024-09-03
SCION
University of British Columbia
Phase 2
Withdrawn
NCT01594892
2019-09-04
DOSIS
Wuerzburg University Hospital
Phase NA
Completed
60 enrolled